Skip to main content
Clinical Trials/NCT05591950
NCT05591950
Completed
Not Applicable

Übersetzung Und Validierung Einer Deutschen Version Der Intensive Care Unit Mobility Scale (IMS) Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)

Charite University, Berlin, Germany1 site in 1 country100 target enrollmentJanuary 24, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle Weakness
Sponsor
Charite University, Berlin, Germany
Enrollment
100
Locations
1
Primary Endpoint
Predictive validity of the IMS
Status
Completed
Last Updated
last year

Overview

Brief Summary

Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS).

The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.

Registry
clinicaltrials.gov
Start Date
January 24, 2023
End Date
February 20, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stefan J Schaller

Deputy Clinical Director

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • Critically ill adults (age: ≥ 18 years)
  • Expected length of stay in ICU \> 24h
  • Ventilation support

Exclusion Criteria

  • Patients transferred from other ICUs
  • Patients with pre-existing functional limitations
  • Patients with functional limitations due to the admission diagnosis (e.g. stroke. with hemiparesis)

Outcomes

Primary Outcomes

Predictive validity of the IMS

Time Frame: approximate 28 days (till ICU discharge)

Predictive validity of the IMS-score performed in the first 24 hours after admission to the ICU for the length of stay in the ICU

Secondary Outcomes

  • Discharge location(approximate at 28 days (at hospital discharge))
  • Duration of mechanical ventilation(approximate 28 days (till ICU discharge))
  • MRC Score(approximate 28 days (till ICU discharge))
  • Hospital LOS(approximate 28 days (till discharge))
  • ICU mortality(approximate 28 days (till ICU discharge))
  • Muscle strength(approximate 28 days (till ICU discharge))
  • IMS during the ICU stay(approximate 28 days (till ICU discharge))
  • in-hospital mortality(approximate 28 days (till discharge))
  • 90-day mortality(at 90 days)
  • 90-day function(at 90 days)
  • ICU-LOS(approximate 28 days (till ICU discharge))

Study Sites (1)

Loading locations...

Similar Trials